CISPLATIN Teva 100 mg/100ml flac 100 ml
7680479980701
Pharmacode 4333164
CH-47998
L01XA01
07.16.1.
1 / 3
google
Details
- GTIN
- 7680479980701
- Pharmacode
- 4333164
- Product number
- 4799802
- CPT
- -
- Packaging group
- 1 x 100mg/100ml
- Unit
- Durchstechflasche(n)
- Composition
- cisplatinum 1 mg, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.545 mg.
Articles (1)
Cisplatin-Teva, 1 mg/ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1 x 100mg/100ml
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
cisplatinum
|
1.0 MG | Substance | Wirkstoff (Principe actif) |
|
natrii chloridum
|
- | Substance | HNIDK |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
3.545 MG | Substance | HBESI |
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 47998
- Drug name
- Cisplatin-Teva, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01XA01
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- A
- First authorization
- 09/10/1987
- Authorization expiration date
- 01/08/2026
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CISPLATIN Teva 100 mg/100ml flac 100 ml
- Description (DE)
- CISPLATIN Teva 100 mg/100ml Durchstf 100 ml
- Market launch
- 21/07/2009
- Market withdrawal
- 30/08/2025
- Narcotic (BTM)
- No